123 related articles for article (PubMed ID: 35613346)
1. On the issue of diagnostic value of determining the level of receptors and their ligands in blood in non-small cell lung cancer.
Murashka DI; Tahanovich AD; Kauhanka MM; Gotko OV; Prokhorova VI
Klin Lab Diagn; 2022 May; 67(5):277-285. PubMed ID: 35613346
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic efficiency of determining CXCR1, CXCR2 and hyaluronic acid blood level in non-small cell lung cancer patients].
Murashka DI; Tahanovich AD; Kauhanka MM; Prokhorova VI; Gotko OV
Biomed Khim; 2021 Sep; 67(5):434-442. PubMed ID: 34730557
[TBL] [Abstract][Full Text] [Related]
3. [Predicting the risk of tumor progression in patients with early stages of adenocarcinoma and squamous cell lung carcinoma based on laboratory parameters].
Tahanovich AD; Kauhanka NN; Prohorova VI; Murashka DI; Gotko OV
Biomed Khim; 2021 Nov; 67(6):507-517. PubMed ID: 34964445
[TBL] [Abstract][Full Text] [Related]
4. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
6. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
[TBL] [Abstract][Full Text] [Related]
7. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.
Smithson A; Sarrias MR; Barcelo J; Suarez B; Horcajada JP; Soto SM; Soriano A; Vila J; Martinez JA; Vives J; Mensa J; Lozano F
Clin Diagn Lab Immunol; 2005 Dec; 12(12):1358-63. PubMed ID: 16339057
[TBL] [Abstract][Full Text] [Related]
9. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
11. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma.
Varney ML; Johansson SL; Singh RK
Am J Clin Pathol; 2006 Feb; 125(2):209-16. PubMed ID: 16393674
[TBL] [Abstract][Full Text] [Related]
13. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
Navarro J
Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
[TBL] [Abstract][Full Text] [Related]
14. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
15. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2.
Lippert U; Zachmann K; Henz BM; Neumann C
Exp Dermatol; 2004 Aug; 13(8):520-5. PubMed ID: 15265017
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass.
Chishti AD; Dark JH; Kesteven P; Powell H; Snowden C; Shenton BK; Kirby JA; Baudouin SV
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1162-6. PubMed ID: 11726891
[TBL] [Abstract][Full Text] [Related]
17. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
[TBL] [Abstract][Full Text] [Related]
18. Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.
Wang RX; Ji P; Gong Y; Shao ZM; Chen S
Breast Cancer Res Treat; 2020 Jun; 181(3):561-570. PubMed ID: 32361849
[TBL] [Abstract][Full Text] [Related]
19. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms in CXCR1, CXCR2 and CXCL5 with Behçet disease: a study in the Denizli province of Turkey.
Arıkan S; Atalay A; Öztürk O; Duygulu Ş; Atalay EÖ
Clin Exp Dermatol; 2021 Dec; 46(8):1462-1470. PubMed ID: 34050991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
